Yield10 Bioscience Inc (OTCPK:YTEN)
$ 1.05 0 (0%) Market Cap: 690,000.00 Enterprise Value: 2.75 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q1 2020 Yield10 Bioscience Inc Earnings Call Transcript

May 14, 2020 / 10:00PM GMT
Release Date Price: $116.16 (-1.22%)
Operator

Welcome to the First Quarter 2020 Financial Results and Business Update Conference Call for Yield10 Bioscience. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference call over to your host, Yield10 Vice President of Planning and Corporate Communications, Ms. Lynne Brum. Ms. Brum, you may begin.

Lynne H. Brum
Yield10 Bioscience, Inc. - VP of Planning & Corporate Communications and Secretary

Thank you, Laura, and good evening, everyone. Welcome to Yield10 Bioscience First Quarter 2020 Conference Call. Joining me on the call today are President and CEO, Dr. Oliver Peoples; Vice President of Research and Chief Science Officer, Dr. Kristi Snell; and Chief Accounting Officer, Chuck Haaser.

Earlier this afternoon, Yield10 issued our first quarter 2020 financial results as well as a press release confirming that permitting is complete for our 2020 field testing program. These releases, as well as slides that accompany today's presentation, are available on the Investor Relations Events

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot